NCTM advises Sacom on acquisition of controlling stake in Agafert
NCTM has advised Sacom on its acquisition of Agafert. The producer and distributor of products for nutrition and plant care signed an investment agreement for the acquisition of a controlling stake in Agafert as part of its growth, based on strategies of internationalisation.
The transaction and acquisition of the entire share capital should be completed by May 2017.
Agafert operates in the trade and distribution of fertilisers and other chemical, and biological products for agriculture, and has strong business relationships in certain foreign markets.
The operation should allow Sacom to strengthen its commercial network in Kenya, Lebanon, Turkey, Malaysia, Kazakhstan, Ukraine, the former Soviet Union countries, Bulgaria, Romania, Greece, Russia, Syria, Egypt and the Dominican Republic.
Sacom was assisted by Movent Capital Advisors on financial matters and by NCTM on legal matters, with a team consisting of Lukas Plattner and Andrea Iovieno.
News from NCTM
Briefings from NCTM
One of the EPO Boards of Appeal has ruled on the highly debated issue of human stem cell patentability under the European Patent Convention.
On 7 February 2014, the European Court of Justice (Case 98-13) issued a ruling pertaining to the interpretation of Council Regulation (EC) no. 1383/2003.
Analysis from The Lawyer
Being sent to London on secondment is a prized opportunity for associates in European firms